Cargando…
Idiopathic pulmonary fibrosis – clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development?
Evidence-based guidelines have undergone an incredible transformation over the last number of years. Significant advances include explicit linkages of systematic evidence summaries to the strength and direction of recommendations, consideration of all patient-important factors, transparent reporting...
Autores principales: | Rochwerg, Bram, Schünemann, Holger J., Raghu, Ganesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748604/ https://www.ncbi.nlm.nih.gov/pubmed/26860831 http://dx.doi.org/10.1186/s12916-016-0563-0 |
Ejemplares similares
-
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
por: Rochwerg, Bram, et al.
Publicado: (2016) -
VICE raises the GRADE: recommendations for CAEP clinical practice guidelines
por: Upadhye, Suneel, et al.
Publicado: (2021) -
Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Raghu, Ganesh, et al.
Publicado: (2022) -
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
por: Raghu, Ganesh
Publicado: (2017) -
BIGG, the international database of GRADE Guidelines
por: Torres, Marcela, et al.
Publicado: (2021)